ProfileGDS4718 / 214464_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 98% 99% 95% 98% 91% 89% 96% 92% 93% 94% 97% 93% 93% 94% 87% 88% 90% 92% 98% 97% 97% 90% 93% 98% 90% 92% 95% 95% 96% 95% 94% 98% 93% 94% 95% 96% 97% 97% 98% 92% 94% 96% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.376795
GSM549102patient 115, normal, homogenized [OPG study]11.283698
GSM549104patient 119, normal, homogenized [OPG study]12.022799
GSM549108patient 138, normal, homogenized [OPG study]10.347395
GSM549119patient 077, normal, homogenized [OPG study]11.783198
GSM549133patient 032, cancer, homogenized [OPG study]9.4753191
GSM549139patient 042, cancer, homogenized [OPG study]8.985389
GSM549099patient 107, normal, homogenized [OPG study]10.546896
GSM549109patient 139, normal, homogenized [OPG study]9.6335392
GSM549110patient 046, normal, homogenized [OPG study]9.8329293
GSM549114patient 063, normal, homogenized [OPG study]10.140194
GSM549122patient 082, normal, homogenized [OPG study]11.135597
GSM549134patient 033, cancer, homogenized [OPG study]9.6827993
GSM549136patient 036, cancer, homogenized [OPG study]9.8741293
GSM549140patient 044, cancer, homogenized [OPG study]10.077294
GSM549111patient 047, normal, homogenized [OPG study]8.7710687
GSM549113patient 057, normal, homogenized [OPG study]9.0404788
GSM549132patient 031, cancer, homogenized [OPG study]9.1321590
GSM549137patient 038, cancer, homogenized [OPG study]9.4792
GSM549142patient 047, cancer, homogenized [OPG study]10.620498
GSM549100patient 110, normal, homogenized [OPG study]10.867197
GSM549107patient 135, normal, homogenized [OPG study]11.014597
GSM549115patient 068, normal, homogenized [OPG study]9.4848890
GSM549116patient 072, normal, homogenized [OPG study]9.8240993
GSM549120patient 078, normal, homogenized [OPG study]11.266498
GSM549131patient 030, cancer, homogenized [OPG study]9.2644590
GSM549118patient 074, normal, homogenized [OPG study]9.5395392
GSM549129patient 027, cancer, homogenized [OPG study]10.026295
GSM549123patient 088, normal, homogenized [OPG study]10.328495
GSM549124patient 006, cancer, homogenized [OPG study]10.361996
GSM549126patient 015, cancer, homogenized [OPG study]10.068795
GSM549128patient 025, cancer, homogenized [OPG study]9.9675394
GSM549103patient 117, normal, homogenized [OPG study]11.33598
GSM549117patient 073, normal, homogenized [OPG study]9.8699293
GSM549138patient 041, cancer, homogenized [OPG study]9.9219794
GSM549141patient 045, cancer, homogenized [OPG study]10.243995
GSM549130patient 028, cancer, homogenized [OPG study]10.440296
GSM549101patient 111, normal, homogenized [OPG study]11.048897
GSM549105patient 128, normal, homogenized [OPG study]11.062897
GSM549106patient 134, normal, homogenized [OPG study]11.529598
GSM549112patient 048, normal, homogenized [OPG study]9.6731892
GSM549125patient 011, cancer, homogenized [OPG study]9.8557894
GSM549127patient 024, cancer, homogenized [OPG study]10.421596
GSM549135patient 035, cancer, homogenized [OPG study]9.7829493